CheckMyRecalls

Mylan Pharmaceuticals Inc recalls Prasugrel Tablets

Published
9 Sept 2026
Units affected
47,662 bottles
Agency
FDA
Country
United States

The hazard

Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 0378-5186-93.

Brand / company
Mylan Pharmaceuticals Inc
Codes / lots
Lot #: 3225272, Exp. September 30, 2026
Distribution
Nationwide within the U.S
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 9 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.